Swedish man­u­fac­tur­er ac­quires Val­ne­va fa­cil­i­ty

NorthX Bi­o­log­ics, a cell and gene ther­a­py man­u­fac­tur­ing and de­vel­op­ment out­fit based in Mat­fors, Swe­den, has ac­quired a fa­cil­i­ty from Val­ne­va.

As part of the deal, NorthX has se­cured Val­ne­va’s mul­ti­pur­pose fa­cil­i­ty in Stock­holm near Karolin­s­ka Uni­ver­si­ty Hos­pi­tal for an undis­closed amount. Ac­cord­ing to a re­lease, the 30 staff mem­bers who op­er­ate the fa­cil­i­ty will join NorthX, bring­ing with them ex­pe­ri­ence in man­u­fac­tur­ing Val­ne­va’s prod­ucts and work­ing on oth­er projects on a con­tract ba­sis. The move is ex­pect­ed to al­low NorthX to boost its man­u­fac­tur­ing ca­pa­bil­i­ties, qual­i­ty con­trol abil­i­ties and oth­er de­vel­op­ment work.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER